Name
V. Abramovitši Perearstikeskus Osaühing
Registry code
10632913
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
29.02.2000 (24)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
313 379 €
71 914 €
23%
2 317 €
(estimate is approximate)
99 959 €
3
Submitted
No tax arrears
72%
57%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Valeri Abramovitš 10.12.1958 (65) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| Tatjana Abramovitš 12.06.1959 (65) | - | Board member | - | Founder |
| 2019 10.06.2020 | 2020 02.06.2021 | 2021 21.02.2022 | 2022 22.06.2023 | 2023 21.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 157 668 € | 173 472 € | 244 337 € | 274 796 € | 313 379 € |
| Net profit (loss) for the period | 48 826 € | 40 651 € | 53 771 € | 76 034 € | 71 914 € |
| Profit Margin | 31% | 23% | 22% | 28% | 23% |
| Current Assets | 80 858 € | 82 121 € | 97 974 € | 75 799 € | 89 909 € |
| Fixed Assets | 108 384 € | 89 694 € | 71 367 € | 49 588 € | 35 938 € |
| Total Assets | 189 242 € | 171 815 € | 169 341 € | 125 387 € | 125 847 € |
| Current Liabilities | 8 729 € | 11 819 € | 18 168 € | 22 986 € | 25 888 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 180 513 € | 159 996 € | 151 173 € | 102 401 € | 99 959 € |
| Employees | 3 | 3 | 3 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 12 046.99 € | 12 264.07 € | 4 |
| 2023 Q4 | - | 11 835.02 € | 12 030.2 € | 4 |
| 2023 Q3 | - | 29 276.77 € | 16 338.37 € | 4 |
| 2023 Q2 | - | 9 431.31 € | 9 579.92 € | 4 |
| 2023 Q1 | - | 10 234.59 € | 10 502.97 € | 4 |
| 2022 Q4 | - | 9 817.02 € | 10 083.48 € | 4 |
| 2022 Q3 | - | 7 854.07 € | 8 046.18 € | 5 |
| 2022 Q2 | - | 22 241.26 € | 10 219.16 € | 4 |
| 2022 Q1 | - | 7 977.32 € | 8 089.98 € | 4 |
| 2021 Q4 | - | 6 770.12 € | 7 156.51 € | 4 |
| 2021 Q3 | - | 6 586.07 € | 6 976.32 € | 4 |
| 2021 Q2 | - | 21 754.45 € | 9 745.26 € | 4 |
| 2021 Q1 | - | 6 027.81 € | 6 354.14 € | 5 |
| 2020 Q4 | - | 4 019.17 € | 4 265.59 € | 5 |
| 2020 Q3 | - | 18 840.51 € | 5 296.95 € | 5 |
| 2020 Q2 | - | 3 704.03 € | 3 978.61 € | 5 |
| 2020 Q1 | - | 3 608.89 € | 3 835.67 € | 5 |
